Skip to main content
PolicySpeak
← All files
SKR

SKR

NGO · Sweden · EU Transparency Register 575775842480-93not in register snapshot

This register number is the organization’s own declaration on its submission. It is not in the 14 Sept 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.

2
positions filed
in the 639 files tracked
2
legislative files
of 639 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 639 consultation files tracked so far (53,766 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track SKR in PolicySpeak: request access →

Work at SKR? so we know who speaks for it.

Follow the files SKR engages with

One email on Tuesdays when a new position is filed on these 2 files, from SKR or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

SKR filed 2 positions on 31 May 2021, across 2 of the 639 legislative files tracked here.

What they argued

Classification, labelling and packaging of substances and mixturesfiled 31 May 2021source

Roadmap CPL — Observations Open public consultation EU Commission It is important that the CLP Regulation is clear and transparent in terms of risk identification, classification and responsibilities of different actors. It is important to extend the area where CLP applies if necessary to reduce risks to human health and the environment. It is not wrong to open up before a completely new group, e.g.

Filed in Swedish · English published by the European Commission

Revision of EU legislation on registration, evaluation, authorisation and restriction of chemicalsfiled 31 May 2021source

It is important that the CLP Regulation is clear and unambiguous in terms of risk identification, classification and the responsibilities of different actors. It is important to expand the area where CLP applies if necessary to reduce risks to human health and the environment. It is not wrong to open up before a completely new group, eg endocrine disruptors, if this is justified.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put SKR next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 119.

Is this your organization?

Everything on this page comes from SKR’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.